JWK 002
Alternative Names: JWK-002Latest Information Update: 24 May 2024
At a glance
- Originator Chengdu Jinweike Biotechnology
- Class Eye disorder therapies; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase 0 Retinoschisis
Most Recent Events
- 17 Nov 2023 Phase-0 for Retinoschisis (In children, In adolescents) in China (Subretinal) (NCT06345898)